surmount-1 tirzepatide non-diabetic weight loss SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, SURMOUNT-1 Trial - Cardionerds Twitter

People switching between tirzepatide and semaglutide need to know how the doses compare

*These statements have not been evaluated by the Food and Drug Administration

Gungor N, Bacha F, Saad R, Janosky J, Arslanian S

Semaglutide is marketed under three brand names to distinguish different indications and formulations: Ozempic (injectable for diabetes), Wegovy (injectable for obesity), and Rybelsus (oral for diabetes)

Aunque comparte el mismo principio activo que Mounjaro (tambin tirzepatida), Zepbound est especficamente indicado para la prdida de peso, mientras que Mounjaro se utiliza para el tratamiento de la diabetes tipo 2

Weight loss through lifestyle modification significantly reduces features of NASH